EKF Diagnostics (LON:EKF – Get Free Report) posted its earnings results on Tuesday. The company reported GBX 1.38 ($0.02) EPS for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%.
EKF Diagnostics Trading Down 4.2 %
Shares of EKF Diagnostics stock opened at GBX 22.28 ($0.29) on Wednesday. EKF Diagnostics has a 1-year low of GBX 18.40 ($0.24) and a 1-year high of GBX 33.80 ($0.44). The stock has a market cap of £99.03 million, a P/E ratio of 20.73 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The stock’s 50 day simple moving average is GBX 23.30 and its 200-day simple moving average is GBX 25.88.
EKF Diagnostics Company Profile
? Point-of-Care analysers in the key areas of Hematology and Diabetes
? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- Why Are Stock Sectors Important to Successful Investing?
- Recession Risk: Is It Going to Happen? Here Are the Key Clues
- What is the Shanghai Stock Exchange Composite Index?
- Best of Both Worlds: 3 ETFs With High Dividend Yields, Low Fees
- How Technical Indicators Can Help You Find Oversold Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
